Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. [electronic resource]
Producer: 20070820Description: 2328-32 p. digitalISSN:- 1007-9327
- Adalimumab
- Adult
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- C-Reactive Protein -- metabolism
- Colitis, Ulcerative -- blood
- Drug Tolerance
- Female
- Humans
- Infliximab
- Injections, Subcutaneous
- Male
- Middle Aged
- Prospective Studies
- Remission Induction
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.